The Latest Breaking News from Pfizer

Thin characterisation and a slightly preachy message hold this 90-minute film back, but its heart is in the right place

As Pfizer (PFE) navigates a post-pandemic world with a shifting focus away from COVID-related products, what should investors expect from this pharma giant? Let’s look at its financial metrics to know more….

Wednesday’s unusual options activity had multiple stocks with two or more calls expiring on the same day. Five stocks caught my interest. Only one of the calls is worth buying.

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

Amid a dismal financial outlook for 2024 and falling sales of COVID-19 products, Pfizer shares see a 7% tumble triggering Wall Street worries.

Pfizer announced Tuesday that it expects to complete this week its $43 billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. The S&P 500 climbed to a 20-month high, while...

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.22%. Stocks this morning are posting modest gains, with the...

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are up +0.17%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.31%. Stock index futures this morning are moderately higher after the U.S. Nov CPI report matched expectations and eased slightly, bolstering speculation the Fed will start cutting interest...